What is China Pharma Holdings, Inc.'s Market Cap?

China Pharma Holdings, Inc.'s Market Cap is $36.2M, based on as-reported figures from SEC (XBRL) filings.

What is China Pharma Holdings, Inc.'s Enterprise Value?

China Pharma Holdings, Inc.'s Enterprise Value is $37.5M, based on as-reported figures from SEC (XBRL) filings.

What is China Pharma Holdings, Inc.'s Price / Sales?

China Pharma Holdings, Inc.'s Price / Sales is 9.2×, based on as-reported figures from SEC (XBRL) filings.

What is China Pharma Holdings, Inc.'s EV / Revenue?

China Pharma Holdings, Inc.'s EV / Revenue is 9.6×, based on as-reported figures from SEC (XBRL) filings.

What is China Pharma Holdings, Inc.'s EV / EBITDA?

China Pharma Holdings, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is China Pharma Holdings, Inc.'s Revenue (TTM)?

China Pharma Holdings, Inc.'s Revenue (TTM) is $3.9M, based on as-reported figures from SEC (XBRL) filings.

What is China Pharma Holdings, Inc.'s Net Income (TTM)?

China Pharma Holdings, Inc.'s Net Income (TTM) is -$4.5M, based on as-reported figures from SEC (XBRL) filings.

What is China Pharma Holdings, Inc.'s EBITDA?

China Pharma Holdings, Inc.'s EBITDA is -$2.9M, based on as-reported figures from SEC (XBRL) filings.

What is China Pharma Holdings, Inc.'s Diluted EPS (TTM)?

China Pharma Holdings, Inc.'s Diluted EPS (TTM) is -0.10, based on as-reported figures from SEC (XBRL) filings.

What is China Pharma Holdings, Inc.'s EBITDA Margin?

China Pharma Holdings, Inc.'s EBITDA Margin is -73.4%, based on as-reported figures from SEC (XBRL) filings.

China Pharma Holdings, Inc. (CPHI) Financial Statements

China Pharma Holdings, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SKGJF7

XASE · usd

0.84▲ 0.02 (2.55%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close0.82

Day's Range0.82 – 0.85

52-Week Range0.38 – 19.19

Volume116.7K

Avg Volume811.3K

Share Statistics

Shares Outstanding

Employees221

ExchangeXASE

Listed2002-04-14

Share count as of August 11, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about China Pharma Holdings, Inc. (CPHI)

What is China Pharma Holdings, Inc.'s Market Cap?: China Pharma Holdings, Inc.'s Market Cap is $36.2M, based on as-reported figures from SEC (XBRL) filings.
What is China Pharma Holdings, Inc.'s Enterprise Value?: China Pharma Holdings, Inc.'s Enterprise Value is $37.5M, based on as-reported figures from SEC (XBRL) filings.
What is China Pharma Holdings, Inc.'s Price / Sales?: China Pharma Holdings, Inc.'s Price / Sales is 9.2×, based on as-reported figures from SEC (XBRL) filings.
What is China Pharma Holdings, Inc.'s EV / Revenue?: China Pharma Holdings, Inc.'s EV / Revenue is 9.6×, based on as-reported figures from SEC (XBRL) filings.
What is China Pharma Holdings, Inc.'s EV / EBITDA?: China Pharma Holdings, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is China Pharma Holdings, Inc.'s Revenue (TTM)?: China Pharma Holdings, Inc.'s Revenue (TTM) is $3.9M, based on as-reported figures from SEC (XBRL) filings.
What is China Pharma Holdings, Inc.'s Net Income (TTM)?: China Pharma Holdings, Inc.'s Net Income (TTM) is -$4.5M, based on as-reported figures from SEC (XBRL) filings.
What is China Pharma Holdings, Inc.'s EBITDA?: China Pharma Holdings, Inc.'s EBITDA is -$2.9M, based on as-reported figures from SEC (XBRL) filings.
What is China Pharma Holdings, Inc.'s Diluted EPS (TTM)?: China Pharma Holdings, Inc.'s Diluted EPS (TTM) is -0.10, based on as-reported figures from SEC (XBRL) filings.
What is China Pharma Holdings, Inc.'s EBITDA Margin?: China Pharma Holdings, Inc.'s EBITDA Margin is -73.4%, based on as-reported figures from SEC (XBRL) filings.